abemaciclib Tablets, film coated 50 mg, 100 mg, 150 mg, 200 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #622
This pharmaceutical company boasts a global reach, with products distributed to over 100 countries. They have a diverse portfolio encompassing over 650 products, primarily focusing on cardiovascular and central nervous system treatments. With a history spanning over a century, they are a well-established player in the industry, demonstrating a strong commitment to innovation and research. Their dedication to R&D is evident in their significant investments and the numerous patents they hold, showcasing their dedication to improving healthcare outcomes. They manufacture both Rx and OTC products, along with active pharmaceutical ingredients, and have a strong track record in the European Union and North America, having achieved relevant GMP approvals for their production lines.

Manufacturer usually replies in 28 days